I agree that this site is using cookies. You can find further informations here.
X
Miner Jr., Philip B.
156  results:
Search for persons X
?
1

Benefit–Risk Assessment of Plecanatide in the Treatment of ..:

Miner Jr., Philip B.
Drug Safety.  42 (2019)  5 - p. 603-615 , 2019
Link: https://doi.org/10.1007/..
 
?
2

Dose-dependent effects of lesogaberan on reflux measures in..:

Miner Jr, Philip B ; Silberg, Debra G ; Ruth, Magnus..
BMC Gastroenterology.  14 (2014)  1 - p. , 2014
Link: https://doi.org/10.1186/..
 
?
3

Exploring the physiologic role of human gastroesophageal re..:

Lu, Luo ; Mu, John C. ; Sloan, Sheldon..
Physiological Reports.  2 (2014)  7 - p. e12051 , 2014
Link: https://doi.org/10.14814..
 
?
4

76 The Prevalence and Natural History of Treatments of Hemo..:

Miner Jr., Philip B. ; Shah, Monil ; Tannenholz, Barry.
Gastroenterology.  142 (2012)  5 - p. S-18 , 2012
Link: https://doi.org/10.1016/..
 
?
5

Long-Term Safety and Effectiveness of Lubiprostone, a Chlor..:

Lembo, Anthony J. ; Johanson, John F. ; Parkman, Henry P....
Digestive Diseases and Sciences.  56 (2011)  9 - p. , 2011
Link: https://doi.org/10.1007/..
 
?
6

Time esophageal pH < 4 overestimates the prevalence of path..:

Gerson, Lauren B ; Triadafilopoulos, George ; Sahbaie, Peyman...
BMC Gastroenterology.  8 (2008)  1 - p. , 2008
Link: https://doi.org/10.1186/..
 
?
7

Spironolactone- and Canrenone-Induced Changes in Hepatic (N..:

Miner Jr., Philip B. ; Sneller, Michael ; Crawford, Synda S.
Hepatology.  3 (2007)  4 - p. 481-488 , 2007
Link: https://doi.org/10.1002/..
 
?
8

Intragastric acidity after switching from 5-day treatment w..:

Miner Jr., Philip B. ; Tutuian, Radu ; Castell, Donald O...
Clinical Therapeutics.  28 (2006)  5 - p. 725-733 , 2006
Link: https://doi.org/10.1016/..
 
?
9

Esophageal Visceral Sensitivity to Bile Salts in Patients w..:

Siddiqui, Ali ; Rodriguez-Stanley, Sheila ; Zubaidi, Sattar.
Digestive Diseases and Sciences.  50 (2005)  1 - p. 81-85 , 2005
Link: https://doi.org/10.1007/..
 
?
10

Seeing Red in Inflammatory Bowel Disease: The Eosinophil at..:

Miner Jr., Philip B.
Inflammatory Bowel Diseases.  10 (2004)  3 - p. 329-330 , 2004
Link: https://doi.org/10.1097/..
 
?
11

Economic and personal impact of fecal and urinary incontine..:

Miner Jr., Philip B
Gastroenterology.  126 (2004)  - p. S8-S13 , 2004
Link: https://doi.org/10.1053/..
 
?
12

The role of mast cells in common gastrointestinal diseases:

Siddiqui, Ali A. ; Miner Jr, Philip B.
Current Allergy and Asthma Reports.  4 (2004)  1 - p. 47-54 , 2004
Link: https://doi.org/10.1007/..
 
?
13

Luminal calcium from chewable antacids improves esophageal ..:

Rodriguez-Stanley Jr., Sheila ; Ahmed, Tanveer ; Zubaidi, Sattar..
Gastroenterology.  124 (2003)  4 - p. A109-A110 , 2003
Link: https://doi.org/10.1016/..
 
?
14

Esomeprazole 40 MG provides more effective intragastric aci..:

Miner Jr., Philip B. ; Katz, Philip O. ; Chen, Yusong.
Gastroenterology.  124 (2003)  4 - p. A229 , 2003
Link: https://doi.org/10.1016/..
 
?
15

Integrated gastric acidity to evaluate acid suppression wit..:

Miner Jr., Philip B. ; Chen, Yusong ; Sostek, Mark B.
Gastroenterology.  124 (2003)  4 - p. A232 , 2003
Link: https://doi.org/10.1016/..
 
1-15